DeSci is revolutionizing the biomedical system through on-chain scientific intellectual property and permissionless markets, driving scientific innovation and the exploration of cures.
Author: @paulkhls
Translation: Plain Language Blockchain
DeSci has been gaining a lot of attention recently, and today I want to share how DeSci and BioDAO currently operate, based on my presentation at the EFDevcon in Bangkok last week.
"DeSci Super Long Article."
DeSci 2049 is a vision for future science that **combines *biotechnology* with permissionless markets driven by open scientific data and open access.**
We know that Bitcoin has achieved permissionless currency, and ETH has achieved permissionless code.
Many of us invest in cryptocurrencies to protect our autonomy and the freedoms that are being slowly and silently stripped away.
A similar movement is forming in the fields of science and medicine, as our freedoms in innovation, self-experimentation, and dissemination of science are being gradually eroded by a failing biomedical R&D system.
Today's system lacks incentives to develop cures. Goldman Sachs downgraded a biopharmaceutical company in 2018 for developing a cure for hepatitis C, questioning whether curing patients was a "sustainable business model."
The death toll from prescription opioids continues to rise. What our system needs is lifelong consumers.
Scientists spend too much time seeking funding instead of focusing on researching science. Imagine if software developers spent most of their time seeking funding instead of writing code.
Most of the scientific talent in the world has yet to be fully utilized. We have failed to achieve a hopeful and prosperous solarpunk future because we have not upgraded the infrastructure of science and technology. This has created a world filled with scientific friction rather than a world of scientific fantasy.
What if we could establish a permissionless scientific world?
Self-sovereign science, defined as being driven by open data and fluid markets, aims to find cures.
So, what roles do @Molecule_dao and @bioprotocol play in this?
Molecule is a protocol that puts scientific intellectual property on-chain.
BIO is an engine that provides launch and acceleration for on-chain scientific communities (BioDAOs), composed of scientists, patients, and investors.
BioDAOs build intellectual property (research, drugs, products) on the blockchain, targeting specific scientific fields or diseases.
For example, @vita_dao has funded multiple projects in the field of longevity science and research, including the VITA-FAST project located at @Vikorolchuk's lab at @UniofNewcastle.
More information about VITA-FAST: https://vitafast.xyz
VITAFAST Token: https://coingecko.com/en/coins/molecules-of-korolchuk-ip-nft
Our team has helped build the first wave of BioDAOs across multiple scientific fields. When I gave this presentation last week, the total market cap of BioDAOs in our network was less than $100 million. Now it has surpassed $230 million!
Source: https://dune.com/kiba/bioconomy
BIO guides scientists, patients, and biotech founders through the process of putting scientific communities on-chain, covering aspects such as token economics, community building, funding, and liquidity.
BIO holders vote to incorporate DAOs into the network—similar to a community-owned accelerator—allowing the best teams to stand out and launch their communities on-chain.
Upcoming projects will be launched on the BIO Launchpad, including @endrarediseases, @QuantumBioDAO, and @longcovidlabs.
Several new BioDAOs focus on specific patient populations, seeking solutions and accelerating new methods of healing.
Curetopia (@endrarediseases) targets the over $1 trillion rare disease sector, led by @eperlste, a Y-Combinator alum, Harvard PhD, and rare disease entrepreneur, who has advanced a drug to Phase 3 clinical trials with just $5 million (far below the typical cost of over $100 million).
https://x.com/bioprotocol/status/1842510500111741056/video/1
Long COVID Labs (@longcovidlabs) is accelerating the search for cures for over 100 million patients worldwide, led by former Stanford neuroscientist @rd108, who self-treated his own long COVID.
**Today, @longcovidlabs is announcing the start of our first study using combination *antiviral treatments* for general eligibility screening.**
@QuantumBioDAO is developing quantum microscopes to observe quantum biological phenomena, led by MIT PhD @ClariceDAiello, one of the world's leading quantum biology scientists:
@geoffanders from Quantum Biology DAO discussed the possibilities of building quantum microscopes that could unlock the following innovations:
• Wearable devices that accelerate muscle recovery
• Mobile applications that launch cell therapies
• Efficient lab-grown meat production
Join @QuantumBioDAO: http://quantumbiology.community
Article link: https://www.hellobtc.com/kp/du/11/5540.html
Source: https://x.com/paulkhls/status/1858546224514941269
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
